Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check6 days agoChange DetectedThe Record History now includes a new entry documenting the addition of Study Status with revision v3.3.3 dated 2025-12-18, and the HHS Vulnerability Disclosure link was removed (revision v3.3.2) on 2025-09-22.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2, indicating a small product/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedThe site-wide notice about lapse in government funding and operating status that was shown on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedNo core study content or scheduling data changed; the observed differences appear to be UI/layout updates on the Record History page, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0; removed the prior v3.1.0 reference.SummaryDifference9%

- Check92 days agoChange DetectedPage now shows v3.1.0 with new Study Status Contacts/Locations (dated 2025-09-19 and 2025-09-22) replacing the prior v3.0.2 from 2025-06-24.SummaryDifference1%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.